Shanghai Henlius Biotech, Inc. (2696.HK) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for HLX22, the company's innovative anti-HER2 monoclonal ...
A generic product cannot enter the market until the originator product’s IP has expired, but the development process can take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback